Healthbiome
2 known investors
Find your way into Healthbiome
Sign up to see every warm intro you have to Healthbiome
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Healthbiome team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HealthBiome is a South Korean biotech venture developing microbiome-based therapeutics targeting intractable diseases such as cancer, dementia, and metabolic disorders. The company focuses on strictly anaerobic, hard-to-culture gut microbiome strains, with capabilities in large-scale anaerobic cultivation, multi-omics analysis, and preclinical animal testing.
Investors · 2
Frequently asked questions
- What does Healthbiome do?
- HealthBiome is a South Korean biotech venture developing microbiome-based therapeutics targeting intractable diseases such as cancer, dementia, and metabolic disorders. The company focuses on strictly anaerobic, hard-to-culture gut microbiome strains, with capabilities in large-scale anaerobic cultivation, multi-omics analysis, and preclinical animal testing.
- Who are Healthbiome's investors?
- Healthbiome's investors include Aju IB Investment, Solidus Investment.